rs6464170

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016203.4(PRKAG2):​c.466+1378G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.315 in 152,096 control chromosomes in the GnomAD database, including 8,539 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8539 hom., cov: 32)

Consequence

PRKAG2
NM_016203.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.19

Publications

3 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.469 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016203.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.466+1378G>C
intron
N/ANP_057287.2
PRKAG2
NM_001407021.1
c.466+1378G>C
intron
N/ANP_001393950.1
PRKAG2
NM_001407022.1
c.466+1378G>C
intron
N/ANP_001393951.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.466+1378G>C
intron
N/AENSP00000287878.3Q9UGJ0-1
PRKAG2
ENST00000392801.6
TSL:1
c.334+1378G>C
intron
N/AENSP00000376549.2Q9UGJ0-3
PRKAG2
ENST00000488258.5
TSL:1
n.466+1378G>C
intron
N/AENSP00000420783.1F8WDA1

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47902
AN:
151978
Hom.:
8517
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.474
Gnomad AMI
AF:
0.344
Gnomad AMR
AF:
0.331
Gnomad ASJ
AF:
0.203
Gnomad EAS
AF:
0.421
Gnomad SAS
AF:
0.232
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.228
Gnomad OTH
AF:
0.332
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.315
AC:
47985
AN:
152096
Hom.:
8539
Cov.:
32
AF XY:
0.315
AC XY:
23456
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.475
AC:
19685
AN:
41474
American (AMR)
AF:
0.332
AC:
5076
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.203
AC:
704
AN:
3470
East Asian (EAS)
AF:
0.421
AC:
2174
AN:
5166
South Asian (SAS)
AF:
0.232
AC:
1117
AN:
4822
European-Finnish (FIN)
AF:
0.246
AC:
2605
AN:
10592
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.228
AC:
15527
AN:
67974
Other (OTH)
AF:
0.333
AC:
701
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1565
3130
4695
6260
7825
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
466
932
1398
1864
2330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.281
Hom.:
855
Bravo
AF:
0.333
Asia WGS
AF:
0.349
AC:
1212
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.41
DANN
Benign
0.43
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6464170; hg19: chr7-151476860; COSMIC: COSV55233680; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.